Birgitta Henriques‐Normark

Author

Also Known As

B. HENRIQUES-NORMARK, B. Henriques-Normark, B. Henriques‐Normark, B., Henriques-Normark, Birgitta Henriques-Normark, Birgitta Henriques-Normark (336864), Birgitta Henriques‐Normark, Henriques-Normark, B., Henriques-Normark, Birgitta

178

Publications

10.2K

Citations

H-Index

131

Concepts

All Affiliations

Karolinska Institutet Karolinska University Hospital Nanyang Technological University Singapore Centre for Environmental Life Sciences Engineering Swedish Institute

About

Birgitta Henriques‐Normark is an author at Karolinska Institutet specializing in medicine, microbiology, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	38	3K
2	Health Sciences	6	6	684
3	Natural Sciences	5	5	207
4	Public Health	2	2	258
5	Engineering	1	1	32

Birgitta Henriques‐Normark

104

Publications

8.2K

Citations

H-Index

Page 1

	Year	Citations
An Endonuclease Allows Streptococcus pneumoniae to Escape from Neutrophil Extracellular Traps Florian Wartha, Barbara Albiger, Staffan Normark, Current Biology Medical MicrobiologyNeutrophil Extracellular TrapsVirulence FactorPathogenesisImmunology	2006	572
Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data Angela B. Brueggemann, Melissa J. Jansen van Rensburg, David R. Shaw, The Lancet Digital Health	2021	515
A pneumococcal pilus influences virulence and host inflammatory responses Michèle A. Barocchi, J. Ries, Xhavit Zogaj, Proceedings of the National Academy of Sciences	2006	472
Capsule and d-alanylated lipoteichoic acids protect Streptococcus pneumoniae against neutrophil extracellular traps Florian Wartha, Barbara Albiger, Jenny Fernebro, Cellular Microbiology ImmunologyBacterial PathogensDrug ResistanceMedical MicrobiologyPathogen Biology	2007	315
Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies Carmen Giefing, Andreas Meinke, Markus Hanner, The Journal of Experimental Medicine	2007	268
A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of <i>Chlamydia trachomatis</i> Sandra Muschiol, Leslie Bailey, Åsa Gylfe, Proceedings of the National Academy of Sciences	2006	193
Aetiology of lower respiratory tract infection in adults in primary care: a prospective study in 11 European countries Margareta Ieven, Samuel Coenen, Katherine Loens, Clinical Microbiology and Infection AsthmaPrimary CareRespiratory DiseasesHealthcare-associated InfectionClinical Epidemiology	2018	167
Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination Germaine Hanquet, Pavla Křížová, Palle Valentiner‐Branth, Thorax	2018	165
Detection of human disease conditions by single-cell morpho-rheological phenotyping of blood Nicole Toepfner, C. Herold, Oliver Otto, eLife Blood CellPathologyConventional Blood AnalysisImmunophenotypingDisease Detection	2018	160
Serotype Replacement after Introduction of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines in 10 Countries, Europe Germaine Hanquet, Pavla Křížová, Shamez Ladhani, Emerging infectious diseases Ipd IncidenceImmunodeficienciesImmunologyBroader Serotype ProtectionVaccine Surveillance	2021	155

Page 1